Professor, Medicine, Medical College of Wisconsin
Hematology
Dr. Janice G. McFarland, MD
|
|
Give Review
Janice G. McFarland, MD is an expert in the field of Hematology. She graduated from Oregon Health & Science University School of Medicine. She has 1 awards "CMS Meaningful Use Stage 1 Certification". Janice McFarland is a published doctor and has 94 publications published. The lastest was: 'Interagency Genome Amplification Testing Task Force: preliminary report.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia/thrombosis (HIT).
- Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.
- Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
- A new low-frequency alloantigen (Kha(b) ) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia.
- Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia.
- Human platelet antigens - 2013.
- Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.
- Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.
- New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia.
- Fetal and Neonatal Alloimmune Thrombocytopenia: A Management Algorithm Based on Risk Stratification.
- Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.
- Dose of prophylactic platelet transfusions and prevention of hemorrhage.
- Neonatal alloimmune thrombocytopenia due to HPA-9b incompatibility.
- Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.
- Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
- Alloimmune thrombocytopenia: state of the art 2006.
- Mechanisms of transfusion-related acute lung injury.
- Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
- Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
- Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
- Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
- Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
- Fetal and neonatal alloimmune thrombocytopenia in pregnancies involving in vitro fertilization: a report of four cases.
- Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies.
- Transfusion support with RBCs from an Mk homozygote in a case of autoimmune hemolytic anemia following diphtheria-pertussis-tetanus vaccination.
- Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets.
- Leucovorin and high-dose fluorouracil in metastatic prostate cancer. A phase II trial of the piedmont Oncology Association.
- Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospec...
- One-tube method for complete HPA-1 genotyping by PCR using sequence-specific primers.
- Perioperative blood transfusions: indications and options.
- A dinucleotide deletion in exon 4 of the PlA2 allelic form of glycoprotein IIIa: implications for the correlation of serologic versus genotypic analysis of human plate...
- A comparison of morphine and methadone disposition in the maternal-fetal unit.
- Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm.
- Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa.
- T cell receptor and alloimmune thrombocytopenias: a model for autoimmune diseases?
- Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
- Transmission of idiopathic (autoimmune) thrombocytopenic purpura by liver transplantation.
- Interagency Genome Amplification Testing Task Force: preliminary report.
- Heparin-induced thrombocytopenia in a child.
- Quantitative determination of platelet surface alloantigens using a monoclonal probe.
- Anti-Bak(a) neonatal alloimmune thrombocytopenia: possible prevention by intravenous immunoglobulin.
- Prenatal diagnosis of neonatal alloimmune thrombocytopenia using an allele-specific oligonucleotide probe.
- Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.
- Paid time off for blood donation--an incentive to be less than truthful?
- Cost-benefit analysis of a plateletapheresis program.
- Laboratory investigation of drug-induced immune thrombocytopenias.
- Platelet and neutrophil alloantigen genotyping in clinical practice.
- Evaluation of four methods for platelet compatibility testing.
- Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel.
- Antivinculin antibodies in sera of patients with immune thrombocytopenia and in sera of normal subjects.
- Patterns of red blood cell use in southeastern Wisconsin.
- Plateletapheresis program. II. Computer selection of HLA compatible donors.
- Prolonged neonatal alloimmune thrombocytopenic purpura associated with anti-Bak(a). Two cases in siblings.
- Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: successful treatment with intravenous gamma globulin.
- Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
- Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow tr...
- In-utero platelet transfusion for alloimmune thrombocytopenia.
- Alloimmunization and platelet transfusion.
- Maternal IVIG in neonatal alloimmune thrombocytopenia.
- Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.
- Amino acid 489 is encoded by a mutational "hot spot" on the beta 3 integrin chain: the CA/TU human platelet alloantigen system.
- Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers.
- An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
- BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura.
- Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura.
- Antenatal treatment of fetal alloimmune cytopenias.
- Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the N...
- Thrombotic thrombocytopenic purpura: early and late responders.
- Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
- Anti-HPA-3A induces severe neonatal alloimmune thrombocytopenia.
- Detection and identification of platelet antibodies and antigens in the clinical laboratory.
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.
- New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.
- Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
- Antiplatelet antibody testing in thrombocytopenic pregnant women.
- Antenatal management of fetal alloimmune and autoimmune thrombocytopenia.
- Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity.
- Antenatal treatment of alloimmune thrombocytopenia.
- Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia.
- Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP).
- Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature.
- Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis.
- Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex.
- Antenatal treatment of neonatal alloimmune thrombocytopenia.
- Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes.
- Fetal alloimmune thrombocytopenia.
- Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin.
- Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody.
- Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility.
- TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
- Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays.
- Detection and identification of platelet antibodies in clinical disorders.
- Transfusion-related acute lung injury: definition and review.
Schools
Oregon Health Sciences University
Doctors Specialties
- Clinical Pathology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Washington -
Duke University Hospital -
Oregon Health & Science University School of Medicine
Hospital
-
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER | 1780608380 | |
| NPPES Provider LastName | MCFARLAND | |
| NPPES Provider FirstName | JANICE | |
| NPPES Provider ZIPCode | 532263522 | |
| NPPES Provider State | WI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 33.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780608380 |
| Last Name Of The Provider | MCFARLAND |
| First Name Of The Provider | JANICE |
| View All |
Similar Doctors
|
Dr. Ehab Atallah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Libnoch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan E. Mast, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra Harrington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahir Z. Bagirov, MD |
|
|
Dr. Luis F. Carrillo, MD |
|
|
Dr. Daniel J. Rowan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle Vargas De Stefano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Marwan S. Al-Akasheh |